Bayer AG (WAR:BAY) E10: zł3.82 (As of Mar. 2026)


WAR:BAY Bayer AG WAR:BAY
44 GF Score
Price zł199.00
GF Value zł116.22
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Bayer AG E10?

Bayer AG WAR:BAY +0.40% 44 E10 is zł3.82 as of Mar. 2026. GuruFocus rates WAR:BAY with a GF Score™ of 44/100 and a GF Value™ of zł116.22 (Significantly Overvalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bayer AG's adjusted earnings per share data for the three months ended in Mar. 2026 was zł11.937. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is zł3.82 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bayer AG's average E10 Growth Rate was -48.90% per year. During the past 3 years, the average E10 Growth Rate was -35.70% per year. During the past 5 years, the average E10 Growth Rate was -20.20% per year. During the past 10 years, the average E10 Growth Rate was -10.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bayer AG was 15.10% per year. The lowest was -35.70% per year. And the median was 4.50% per year.

As of today (2026-06-27), Bayer AG's current stock price is zł199.00. Bayer AG's E10 for the quarter that ended in Mar. 2026 was zł3.82. Bayer AG's Shiller PE Ratio of today is 52.09.

During the past 13 years, the highest Shiller PE Ratio of Bayer AG was 54.10. The lowest was 10.07. And the median was 17.24.


Bayer AG  (WAR:BAY) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bayer AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=199.00/3.82
=52.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bayer AG was 54.10. The lowest was 10.07. And the median was 17.24.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bayer AG E10 Related Terms


Bayer AG E10 Historical Data

* Premium members only.

The historical data trend for Bayer AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer AG E10 Chart

Bayer AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 11.22 7.53 3.54

Bayer AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.42 6.68 5.50 3.54 3.82

WAR:BAY vs LLY, JNJ, ABBV: E10 Comparison

For the Drug Manufacturers - General subindustry, Bayer AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Shiller PE Ratio falls into.


WAR:BAY
44GF Score
Bayer AG WAR:BAY
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=11.937/131.2583*131.2583
=11.937

Current CPI (Mar. 2026) = 131.2583.

Bayer AG Quarterly Data

per share eps CPI Adj_EPS
201606 6.895 100.717 8.986
201609 5.898 101.017 7.664
201612 1.977 101.217 2.564
201703 9.393 101.417 12.157
201706 5.698 102.117 7.324
201709 19.183 102.717 24.513
201712 0.739 102.617 0.945
201803 10.013 102.917 12.770
201806 3.735 104.017 4.713
201809 12.563 104.718 15.747
201812 -17.809 104.217 -22.430
201903 5.273 104.217 6.641
201906 1.702 105.718 2.113
201909 4.249 106.018 5.261
201912 5.879 105.818 7.292
202003 6.172 105.718 7.663
202006 -40.222 106.618 -49.518
202009 -12.076 105.818 -14.979
202012 1.431 105.518 1.780
202103 9.318 107.518 11.375
202106 -10.537 108.486 -12.749
202109 0.389 109.435 0.467
202112 4.899 110.384 5.825
202203 13.557 113.968 15.614
202206 -1.165 115.760 -1.321
202209 2.037 118.818 2.250
202212 2.413 119.345 2.654
202303 8.734 122.402 9.366
202306 -7.644 123.140 -8.148
202309 -18.275 124.195 -19.314
202312 5.490 123.773 5.822
202403 8.148 125.038 8.553
202406 -0.119 125.882 -0.124
202409 -17.374 126.198 -18.071
202412 -1.308 127.041 -1.351
202503 5.244 127.779 5.387
202506 -0.848 128.412 -0.867
202509 -4.227 129.255 -4.293
202512 -16.437 129.361 -16.678
202603 11.937 131.258 11.937

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of zł3.82 mean?
Bayer AG (WAR:BAY) has a E10 of zł3.82 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bayer AG and its competitors.
Is Bayer AG's E10 too high?
Bayer AG's current E10 is zł3.82. Overall, Bayer AG has a GF Score™ of 44/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bayer AG's E10 compare to LLY and JNJ?
Bayer AG's E10 of zł3.82 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bayer AG and its competitors. Bayer AG's current E10 is zł3.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer AG stock overvalued right now?
Based on GuruFocus' analysis, Bayer AG (WAR:BAY) is currently considered Significantly Overvalued. The stock's GF Value™ is zł116.22, compared to a current price of zł199.00 — trading 71.2% above its estimated fair value. The current E10 is zł3.82. Bayer AG's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bayer AG (WAR:BAY), the current E10 is zł3.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer AG (WAR:BAY) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer AG stock appears to be overvalued. The current stock price of zł199.00 is trading 71.2% above its estimated GF Value™ of zł116.22. GuruFocus considers Bayer AG to be Significantly Overvalued.

Key valuation signals for WAR:BAY:

  • E10: zł3.82
  • GF Value™: zł116.22 vs. price of zł199.00 (71.2% above fair value)
  • GF Score™: 44/100 with 2 warning signs

No single metric tells the full story. See the WAR:BAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer AG Business Description

Address Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs (about 38% of total sales in 2025) as well as vitamins and other consumer healthcare products (13% of total). The firm's crop science business (47% of total) sells seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.
44GF Score

Get the complete analysis for WAR:BAY

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł199.00
Price
zł116.22
GF Value